| PACKAGING TYPE: | 10ml C-box |
| COMPOSITION: | Rabeprazole 20mg Injection |
| FORMULATION: | Injection |
| Description: | RABSIP-20 Injection contains Rabeprazole 20 mg, a proton pump inhibitor (PPI) used to suppress gastric acid secretion. It works by inhibiting the H⁺/K⁺-ATPase enzyme (proton pump) in the stomach lining, thereby reducing acid production. It is commonly used in the management of gastroesophageal reflux disease (GERD), peptic ulcer disease, Zollinger–Ellison syndrome, and prevention of stress ulcers in critically ill patients. The injectable form is ideal for hospital use when oral therapy is not feasible or rapid acid control is required. |
| Side Effects: | Headache Nausea or vomiting Abdominal discomfort Diarrhea or constipation Injection site reactions |
| How to Use: | To be administered by healthcare professionals only Given via IV injection or infusion Dosage as prescribed by physician Reconstitute and administer as per guidelines |
| Precaution: | For hospital use only Use cautiously in patients with liver impairment Long-term use may affect Vitamin B12 absorption Monitor during prolonged therapy Not for self-administration |
| Product Benefits: | Effective and rapid acid suppression Useful in GERD and peptic ulcer disease Helps in healing gastric and duodenal ulcers Prevents stress-related mucosal damage Suitable for ICU and hospitalized patients Alternative PPI option in clinical practice |
Frequently Asked Questions
It is used for acid-related disorders like GERD and ulcers.
Rabeprazole has a rapid onset and is effective in acid suppression.
When oral administration is not possible or in critical care settings.











